• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状突变携带者和 GBA 相关帕金森病患者的单核细胞衍生巨噬细胞中的比较转录组分析。

Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic Mutation Carriers and Patients with GBA-Associated Parkinson's Disease.

机构信息

Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre «Kurchatov Institute», Gatchina 188300, Russia.

Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg 197022, Russia.

出版信息

Genes (Basel). 2021 Sep 29;12(10):1545. doi: 10.3390/genes12101545.

DOI:10.3390/genes12101545
PMID:34680941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8535749/
Abstract

Mutations of the gene, encoding for lysosomal enzyme glucocerebrosidase (GCase), are the greatest genetic risk factor for Parkinson's disease (PD) with frequency between 5% and 20% across the world. N370S and L444P are the two most common mutations in the gene. PD carriers of severe mutation L444P in the gene is characterized by the earlier age at onset compared to N370S. Not every carrier of mutations develop PD during one's lifetime. In the current study we aimed to find common gene expression signatures in PD associated with mutation in the gene (GBA-PD) using RNA-seq. We compared transcriptome of monocyte-derived macrophages of 5 patients with GBA-PD (4 L444P/N, 1 N370S/N) and 4 asymptomatic mutation carriers (GBA-carriers) (3 L444P/N, 1 N370S/N) and 4 controls. We also conducted comparative transcriptome analysis for L444P/N only GBA-PD patients and GBA-carriers. Revealed deregulated genes in GBA-PD independently of mutations (L444P or N370S) were involved in immune response, neuronal function. We found upregulated pathway associated with zinc metabolism in L444P/N GBA-PD patients. The potential important role of in the pathogenesis of GBA-PD was suggested.

摘要

基因的突变,编码溶酶体酶葡萄糖脑苷脂酶(GCase),是帕金森病(PD)最大的遗传风险因素,在全球范围内频率为 5%至 20%。N370S 和 L444P 是 基因中最常见的两种突变。携带严重突变 L444P 的 PD 患者的发病年龄早于 N370S。并非每个携带 基因突变的患者在其一生中都会发展为 PD。在本研究中,我们旨在使用 RNA-seq 寻找与 基因(GBA-PD)突变相关的 PD 常见基因表达特征。我们比较了 5 名 GBA-PD(4 名 L444P/N,1 名 N370S/N)和 4 名无症状 基因突变携带者(GBA-携带者)(3 名 L444P/N,1 名 N370S/N)和 4 名对照者的单核细胞来源的巨噬细胞转录组。我们还对仅 L444P/N 的 GBA-PD 患者和 GBA-携带者进行了比较转录组分析。在 GBA-PD 中独立于突变(L444P 或 N370S)下调的基因参与免疫反应、神经元功能。我们发现 L444P/N GBA-PD 患者中与锌代谢相关的上调途径。提示 基因在 GBA-PD 发病机制中可能具有重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/11c4279a871c/genes-12-01545-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/1e4644be822c/genes-12-01545-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/44b6991467e4/genes-12-01545-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/bc4c2f71c9bb/genes-12-01545-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/c0005a472fe7/genes-12-01545-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/dd63393f6b08/genes-12-01545-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/11c4279a871c/genes-12-01545-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/1e4644be822c/genes-12-01545-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/44b6991467e4/genes-12-01545-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/bc4c2f71c9bb/genes-12-01545-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/c0005a472fe7/genes-12-01545-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/dd63393f6b08/genes-12-01545-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bda/8535749/11c4279a871c/genes-12-01545-g006.jpg

相似文献

1
Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic Mutation Carriers and Patients with GBA-Associated Parkinson's Disease.无症状突变携带者和 GBA 相关帕金森病患者的单核细胞衍生巨噬细胞中的比较转录组分析。
Genes (Basel). 2021 Sep 29;12(10):1545. doi: 10.3390/genes12101545.
2
β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.β-葡萄糖脑苷脂酶基因突变在两组希腊散发性帕金森病患者中。
Mol Genet Metab. 2011 Sep-Oct;104(1-2):149-52. doi: 10.1016/j.ymgme.2011.06.015. Epub 2011 Jun 24.
3
Decreased Penetrance of Parkinson's Disease in Elderly Carriers of Glucocerebrosidase Gene L444P/R Mutations: A Community-Based 10-Year Longitudinal Study.载脂蛋白 E ε4 等位基因与帕金森病的相关性:一项基于人群的 10 年纵向研究。
Mov Disord. 2020 Apr;35(4):672-678. doi: 10.1002/mds.27971. Epub 2020 Jan 8.
4
Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.在来自加拿大东部的帕金森病患者中,葡萄糖脑苷脂酶基因突变很常见。
Int J Neurosci. 2016;126(5):415-21. doi: 10.3109/00207454.2015.1023436. Epub 2015 Aug 18.
5
Mutations of glucocerebrosidase gene and susceptibility to Parkinson's disease: An updated meta-analysis in a European population.葡萄糖脑苷脂酶基因突变与帕金森病易感性:欧洲人群的一项更新的荟萃分析
Neuroscience. 2016 Apr 21;320:239-46. doi: 10.1016/j.neuroscience.2016.02.007. Epub 2016 Feb 8.
6
Glucocerebrosidase gene L444P mutation is a risk factor for Parkinson's disease in Chinese population.葡萄糖脑苷脂酶基因 L444P 突变是中国人帕金森病的危险因素。
Mov Disord. 2010 Jun 15;25(8):1005-11. doi: 10.1002/mds.23009.
7
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.伴有和不伴有GBA突变的帕金森病中的葡萄糖脑苷脂酶活性
Brain. 2015 Sep;138(Pt 9):2648-58. doi: 10.1093/brain/awv179. Epub 2015 Jun 27.
8
Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan.在台湾的一个大型散发性帕金森病队列中,葡萄糖脑苷脂酶突变的贡献。
Eur J Neurol. 2011 Oct;18(10):1227-32. doi: 10.1111/j.1468-1331.2011.03362.x. Epub 2011 Feb 22.
9
Features of -associated Parkinson's disease at presentation in the UK study.英国研究中 - 关联帕金森病的发病特征。
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.
10
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.GBA突变型帕金森病中的葡萄糖脑苷脂酶活性
J Clin Neurosci. 2016 Jun;28:185-6. doi: 10.1016/j.jocn.2015.12.004. Epub 2016 Feb 5.

引用本文的文献

1
Autophagy Process in Parkinson's Disease Depends on Mutations in the GBA1 and LRRK2 Genes.帕金森病中的自噬过程取决于GBA1和LRRK2基因的突变。
Biochem Genet. 2025 May 19. doi: 10.1007/s10528-025-11125-z.
2
Large-scale proteomics analysis of five brain regions from Parkinson's disease patients with a GBA1 mutation.对携带GBA1突变的帕金森病患者五个脑区进行的大规模蛋白质组学分析
NPJ Parkinsons Dis. 2024 Feb 8;10(1):33. doi: 10.1038/s41531-024-00645-x.
3
Whole Transcriptome Analysis of Substantia Nigra in Mice with MPTP-Induced Parkinsonism Bearing Defective Glucocerebrosidase Activity.

本文引用的文献

1
Dopamine neuron-specific LRRK2 G2019S effects on gene expression revealed by translatome profiling.通过翻译组学分析揭示多巴胺能神经元特异性 LRRK2 G2019S 对基因表达的影响。
Neurobiol Dis. 2021 Jul;155:105390. doi: 10.1016/j.nbd.2021.105390. Epub 2021 May 11.
2
Synaptic Zinc: An Emerging Player in Parkinson's Disease.突触锌:帕金森病的新角色。
Int J Mol Sci. 2021 Apr 29;22(9):4724. doi: 10.3390/ijms22094724.
3
Emerging Role of AP-1 Transcription Factor JunB in Angiogenesis and Vascular Development.AP-1 转录因子 JunB 在血管生成和血管发育中的新兴作用。
MPTP 诱导的葡萄糖脑苷脂酶活性缺陷帕金森病小鼠黑质全转录组分析。
Int J Mol Sci. 2023 Jul 29;24(15):12164. doi: 10.3390/ijms241512164.
4
Special Issue "Parkinson's Disease: Genetics and Pathogenesis".特刊:帕金森病:遗传学与发病机制
Genes (Basel). 2023 Mar 17;14(3):737. doi: 10.3390/genes14030737.
5
Neuroinflammation and Immune Changes in Prodromal Parkinson's Disease and Other Synucleinopathies.神经炎症与前驱帕金森病及其他突触核蛋白病中的免疫改变。
J Parkinsons Dis. 2022;12(s1):S149-S163. doi: 10.3233/JPD-223245.
6
Immune Response Modifications in the Genetic Forms of Parkinson's Disease: What Do We Know?帕金森病遗传形式中的免疫反应修饰:我们了解多少?
Int J Mol Sci. 2022 Mar 23;23(7):3476. doi: 10.3390/ijms23073476.
Int J Mol Sci. 2021 Mar 10;22(6):2804. doi: 10.3390/ijms22062804.
4
Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism.氨溴索增加葡萄糖脑苷脂酶(GCase)活性,并恢复戈谢病和帕金森病患者原代巨噬细胞中的 GCase 易位。
Parkinsonism Relat Disord. 2021 Mar;84:112-121. doi: 10.1016/j.parkreldis.2021.02.003. Epub 2021 Feb 10.
5
EGR1 is a gatekeeper of inflammatory enhancers in human macrophages.EGR1是人类巨噬细胞中炎症增强子的守门人。
Sci Adv. 2021 Jan 13;7(3). doi: 10.1126/sciadv.aaz8836. Print 2021 Jan.
6
Dual-specificity phosphatases in mental and neurological disorders.双特异性磷酸酶与精神和神经疾病。
Prog Neurobiol. 2021 Mar;198:101906. doi: 10.1016/j.pneurobio.2020.101906. Epub 2020 Sep 6.
7
Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: A Kin Cohort Study.帕金森病中葡萄糖脑苷脂酶(GBA)突变的外显率:一项近亲队列研究。
Mov Disord. 2020 Nov;35(11):2111-2114. doi: 10.1002/mds.28200. Epub 2020 Aug 7.
8
Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson's Disease.溶酶体贮积症揭示了帕金森病中溶酶体功能障碍。
Int J Mol Sci. 2020 Jul 14;21(14):4966. doi: 10.3390/ijms21144966.
9
Plasma Cytokines Profile in Patients with Parkinson's Disease Associated with Mutations in GBA Gene.帕金森病伴 GBA 基因突变患者的血浆细胞因子谱。
Bull Exp Biol Med. 2020 Feb;168(4):423-426. doi: 10.1007/s10517-020-04723-x. Epub 2020 Mar 7.
10
Functional assessment of glucocerebrosidase modulator efficacy in primary patient-derived macrophages is essential for drug development and patient stratification.对原发性患者来源巨噬细胞中葡萄糖脑苷脂酶调节剂疗效进行功能评估,对于药物开发和患者分层至关重要。
Haematologica. 2020 May;105(5):e206-e209. doi: 10.3324/haematol.2019.224717. Epub 2019 Sep 26.